{"id":"W2921697223","doi":"10.1200/jco.2019.37.7_suppl.564","title":"Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk patients (pts) with advanced renal cell carcinoma (aRCC) from CheckMate 214.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Discontinuation; Nivolumab; Internal medicine; Ipilimumab; Sunitinib; Gastroenterology; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001243243,0.0002889853,0.0006976307,0.0002986629,0.0002166897,0.0004271077,0.0003408236,0.0004516364,0.001792628],"category_scores_gemma":[0.001421785,0.0001405875,0.001147256,0.0002685466,0.0002956573,0.0005444789,0.0003250008,0.001250644,0.0001511627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007416462,"about_ca_system_score_gemma":0.0005587227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007573229,"about_ca_topic_score_gemma":0.001433927,"domain_scores_codex":[0.9996062,0.0001257491,0.00003030723,0.00008486929,0.00004327462,0.0001096467],"domain_scores_gemma":[0.9985744,0.0004227441,0.0004686498,0.00005917304,0.00003416462,0.0004408326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7248635,0.007163744,0.1535283,0.000501756,0.001686664,0.0003188222,0.0002988914,0.005429259,0.007683274,0.0002630081,0.001952887,0.09630983],"study_design_scores_gemma":[0.03503233,0.4188829,0.5280721,0.0001201629,0.002399305,0.0006825543,0.0002083975,0.006009254,0.004317679,0.0006087997,0.003607645,0.00005903667],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998534,0.0005741963,0.0000914342,0.00003425825,0.00001726815,0.00005864392,0.0003311731,0.000005204884,0.0003539247],"genre_scores_gemma":[0.9986798,0.0001941512,0.00008436837,0.00004999189,0.00002795139,0.0001001659,0.0005850763,0.000002137207,0.0002763042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001792628,"threshold_uncertainty_score":0.006574988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04489977160114744,"score_gpt":0.3390885531561961,"score_spread":0.2941887815550486,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}